Is IFRX or IMA more undervalued in 2026?

CirclFi compares InflaRx N.V. (IFRX) and ImageneBio, Inc. (IMA) using 13 institutional-grade valuation models. IFRX has a Quality of Company score of 1.8/10 while IMA scores 5.8/10.

Which is a better buy — IFRX or IMA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IFRX and IMA valuations compare?

IFRX at $2.38 and IMA at $5.92 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IFRX vs IMA Valuation Comparison 2026 — Intrinsic Value Analysis

IFRX

Biotechnology

InflaRx N.V.

Quality

1.8

out of 10

Value Trap

—

Price

$2.38

Last close

Models

7/13

Active

IMA

Biotechnology

ImageneBio, Inc.

Quality

5.8

out of 10

Value Trap

LOW

Price

$5.92

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	IFRX Fair Value	IFRX Upside	IMA Fair Value	IMA Upside
Bayesian DCF	Intrinsic	$0.63	-73.5%	$6.30	+11.4%
Earnings Power Value	Intrinsic	—	—	$8.75	+54.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$0.89	-65.3%	$6.69	+18.2%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IFRX vs IMA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IFRX vs IMA — Which Stock Is More Undervalued?

IMA scores higher with a 5.8/10 quality rating vs IFRX's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing InflaRx N.V. (IFRX) and ImageneBio, Inc. (IMA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IFRX currently trades at $2.38 with a QOC of 1.8/10, while IMA trades at $5.92 with a QOC of 5.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).